|

Standard systemic therapy Clinical Trials

3 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Vastra Gotaland Region1
  • Magnus Nilsson1
  • Fudan University1

Indications

  • Cancer3
  • Gastric Cancer Peritoneal Metastases1
  • Microsatellite Stable Metastatic Colorectal Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other3 trials

Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
Phase 3
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
Phase 3
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.